The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 27, 2023 | Mazaltov Avi | Head Global MFG&GM-SciVac Ltd. | Grant(A) | 53K | — | $0 |
| Jul 27, 2023 | McKee Blaine H. | Director | Grant(A) | 35K | — | $0 |
| Jul 27, 2023 | Anderson David Evander | Chief Scientific Officer | Grant(A) | 53K | — | $0 |
| Jul 27, 2023 | Diaz-Mitoma Francisco | Chief Medical Officer | Grant(A) | 53K | — | $0 |
| Jul 27, 2023 | Baxter Jeff | CEO, President, Director | Grant(A) | 70K | — | $0 |
| Jul 27, 2023 | Cordeiro Joanne | Director | Grant(A) | 35K | — | $0 |
| Jul 27, 2023 | Dillman John Robert | Chief Commercial Officer | Grant(A) | 53K | — | $0 |
| Jul 27, 2023 | Beattie Nell | CFO, Head of Corp. Development, Director | Grant(A) | 53K | — | $0 |
| Jul 27, 2023 | Gillis Steven | Director | Grant(A) | 53K | — | $0 |
| Jul 27, 2023 | Himes Vaughn B | Director | Grant(A) | 35K | — | $0 |
| Jul 27, 2023 | Braga Damian | Director | Grant(A) | 35K | — | $0 |
| Jul 27, 2023 | DeWilde Michel | Director | Grant(A) | 35K | — | $0 |
| Jul 10, 2023 | Gillis Steven | Director | Buy(P) | 609K | $1.65 | $1.0M |
| Jul 10, 2023 | Gillis Steven | Director | Buy(P) | 609K | — | — |
| Apr 27, 2023 | Himes Vaughn B | Director | Grant(A) | 8K | — | $0 |
| Apr 6, 2023 | Perceptive Advisors LLC | 10% Owner | Sell(S) | 4.3M | $0.11 | $468K |
| Apr 5, 2023 | Perceptive Advisors LLC | 10% Owner | Sell(S) | 1.8M | $0.13 | $238K |
| Apr 4, 2023 | Perceptive Advisors LLC | 10% Owner | Sell(S) | 4.8M | $0.16 | $770K |
| Jan 26, 2023 | McKee Blaine H. | Director | Grant(A) | 50K | — | $0 |
| Jan 26, 2023 | McNulty Christopher | CFO and Head of BD, Director | Grant(A) | 75K | — | $0 |
| Jan 26, 2023 | Beattie Nell | Chief Business Officer | Grant(A) | 75K | — | $0 |
| Jan 26, 2023 | Diaz-Mitoma Francisco | Chief Medical Officer | Grant(A) | 75K | — | $0 |
| Jan 26, 2023 | Anderson David Evander | Chief Scientific Officer | Grant(A) | 75K | — | $0 |
| Jan 26, 2023 | Braga Damian | Director | Grant(A) | 50K | — | $0 |
| Jan 26, 2023 | Baxter Jeff | CEO, President, Director | Grant(A) | 100K | — | $0 |
| Jan 26, 2023 | Dillman John Robert | Chief Commercial Officer | Grant(A) | 75K | — | $0 |
| Jan 26, 2023 | Cordeiro Joanne | Director | Grant(A) | 50K | — | $0 |
| Jan 26, 2023 | Gillis Steven | Director | Grant(A) | 75K | — | $0 |
| Jan 26, 2023 | DeWilde Michel | Director | Grant(A) | 50K | — | $0 |
| Jan 26, 2023 | Mazaltov Avi | Head Global MFG&GM-SciVac Ltd. | Grant(A) | 75K | — | $0 |
| Jul 7, 2022 | Dillman John Robert | Chief Commercial Officer | Grant(A) | 100K | — | $0 |
| Jan 27, 2022 | Anderson David Evander | Chief Scientific Officer | Grant(A) | 400K | — | $0 |
| Jan 27, 2022 | Bain Linda | Director | Grant(A) | 75K | — | $0 |
| Jan 27, 2022 | Baxter Jeff | CEO, President, Director | Grant(A) | 800K | — | $0 |
| Jan 27, 2022 | Beattie Nell | Chief Business Officer | Grant(A) | 400K | — | $0 |
| Jan 27, 2022 | Braga Damian | Director | Grant(A) | 75K | — | $0 |
| Jan 27, 2022 | Cordeiro Joanne | Director | Grant(A) | 75K | — | $0 |
| Jan 27, 2022 | Diaz-Mitoma Francisco | Chief Medical Officer | Grant(A) | 400K | — | $0 |
| Jan 27, 2022 | Gillis Steven | Director | Grant(A) | 100K | — | $0 |
| Jan 27, 2022 | Mazaltov Avi | Head Global MFG&GM-SciVac Ltd. | Grant(A) | 400K | — | $0 |
| Jan 27, 2022 | McKee Blaine H. | Director | Grant(A) | 75K | — | $0 |
| Jan 27, 2022 | McNulty Christopher | CFO and Head of BD, Director | Grant(A) | 400K | — | $0 |
| Jan 27, 2022 | DeWilde Michel | Director | Grant(A) | 75K | — | $0 |
| Dec 3, 2021 | Beattie Nell | Chief Business Officer | Buy(P) | 8K | $2.45 | $20K |
| Dec 1, 2021 | Edelman Joseph | 10% Owner | Sell(S) | 2.7M | $3.31 | $9.0M |
| Jul 1, 2021 | Bain Linda | Director | Grant(A) | 250K | — | $0 |
| Jun 29, 2021 | Perceptive Life Sciences Master Fund Ltd | 10% Owner | Sell(S) | 501K | $3.80 | $1.9M |
| Jun 29, 2021 | Perceptive Life Sciences Master Fund Ltd | 10% Owner | Sell(S) | 146K | $3.80 | $553K |
| Jun 9, 2021 | Perceptive Advisors LLC | 10% Owner | Option exercise(X) | 1.6M | — | $0 |
| Jun 9, 2021 | Perceptive Advisors LLC | 10% Owner | Option exercise(X) | 466K | — | $0 |
| Jun 9, 2021 | Perceptive Advisors LLC | 10% Owner | Option exercise(X) | 466K | $2.75 | $1.3M |
| Jun 9, 2021 | Perceptive Advisors LLC | 10% Owner | Sell(S) | 1.1M | $4.00 | $4.4M |
| Jun 9, 2021 | Perceptive Advisors LLC | 10% Owner | Sell(S) | 320K | $4.00 | $1.3M |
| Jun 9, 2021 | Perceptive Advisors LLC | 10% Owner | Option exercise(X) | 1.6M | $2.75 | $4.4M |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).